• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

O-连接的N-乙酰葡糖胺转移酶抑制剂的发现。

Discovery of O-GlcNAc transferase inhibitors.

作者信息

Gross Benjamin J, Kraybill Brian C, Walker Suzanne

机构信息

Department of Microbiology and Molecular Genetics, Harvard Medical School, Boston, Massachusetts 02115, USA.

出版信息

J Am Chem Soc. 2005 Oct 26;127(42):14588-9. doi: 10.1021/ja0555217.

DOI:10.1021/ja0555217
PMID:16231908
Abstract

O-GlcNAcylation of serine and threonine residues is a dynamic and essential post-translational modification involved in signaling pathways in eukaryotes. Studies of O-GlcNAcylation would be aided by small-molecule inhibitors of O-GlcNAc transferase (OGT), the sole enzyme know to mediate this modification, but discovery of such molecules has been hampered by poor expression of cloned OGT and lack of suitable high-throughput screens. This Communication describes the development an expression system to access large amounts of the catalytic domain of OGT and the implementation of a fluorescence-based substrate analogue displacement assay that has led to the discovery of a set of OGT inhibitors. This work lays the foundation for both structural and functional analysis of the catalytic domain of OGT.

摘要

丝氨酸和苏氨酸残基的O-连接N-乙酰葡糖胺化是一种动态且重要的翻译后修饰,参与真核生物的信号通路。O-连接N-乙酰葡糖胺转移酶(OGT)的小分子抑制剂有助于对O-连接N-乙酰葡糖胺化进行研究,OGT是已知介导这种修饰的唯一酶,但克隆OGT的低表达以及缺乏合适的高通量筛选方法阻碍了此类分子的发现。本通讯描述了一种表达系统的开发,该系统可获得大量OGT催化结构域,并实施了基于荧光的底物类似物置换测定法,从而发现了一组OGT抑制剂。这项工作为OGT催化结构域的结构和功能分析奠定了基础。

相似文献

1
Discovery of O-GlcNAc transferase inhibitors.O-连接的N-乙酰葡糖胺转移酶抑制剂的发现。
J Am Chem Soc. 2005 Oct 26;127(42):14588-9. doi: 10.1021/ja0555217.
2
O-GlcNAc transferase inhibitors: current tools and future challenges.O-连接的N-乙酰葡糖胺转移酶抑制剂:当前工具与未来挑战
Biochem Soc Trans. 2016 Feb;44(1):88-93. doi: 10.1042/BST20150189.
3
Versatile O-GlcNAc transferase assay for high-throughput identification of enzyme variants, substrates, and inhibitors.用于高通量鉴定酶变体、底物和抑制剂的通用O-连接N-乙酰葡糖胺转移酶检测方法。
Bioconjug Chem. 2014 Jun 18;25(6):1025-30. doi: 10.1021/bc5001774. Epub 2014 Jun 2.
4
A small molecule that inhibits OGT activity in cells.一种可抑制细胞中OGT活性的小分子。
ACS Chem Biol. 2015 Jun 19;10(6):1392-7. doi: 10.1021/acschembio.5b00004. Epub 2015 Mar 18.
5
Bisubstrate Ether-Linked Uridine-Peptide Conjugates as O-GlcNAc Transferase Inhibitors.双底物醚键连接的尿嘧啶-肽缀合物作为 O-GlcNAc 转移酶抑制剂。
ChemMedChem. 2021 Feb 4;16(3):477-483. doi: 10.1002/cmdc.202000582. Epub 2020 Oct 23.
6
O-GlcNAc Transferase: Structural Characteristics, Catalytic Mechanism and Small-Molecule Inhibitors.O-连接的 N-乙酰氨基葡萄糖转移酶:结构特征、催化机制和小分子抑制剂。
Chembiochem. 2020 Nov 2;21(21):3026-3035. doi: 10.1002/cbic.202000194. Epub 2020 Jun 22.
7
Substrate and product analogues as human O-GlcNAc transferase inhibitors.作为人类 O-连接糖基化转移酶抑制剂的底物和产物类似物。
Amino Acids. 2011 Mar;40(3):781-92. doi: 10.1007/s00726-010-0688-y. Epub 2010 Jul 17.
8
O-GlcNAcase: Emerging Mechanism, Substrate Recognition and Small-Molecule Inhibitors.O-GlcNAcase:新兴机制、底物识别及小分子抑制剂。
ChemMedChem. 2020 Jul 20;15(14):1244-1257. doi: 10.1002/cmdc.202000077. Epub 2020 Jun 16.
9
Novel bisubstrate uridine-peptide analogues bearing a pyrophosphate bioisostere as inhibitors of human O-GlcNAc transferase.新型双底物尿嘧啶-肽类似物,含有焦磷酸生物等排体,作为人 O-GlcNAc 转移酶抑制剂。
Bioorg Chem. 2021 May;110:104738. doi: 10.1016/j.bioorg.2021.104738. Epub 2021 Feb 13.
10
New ELISA-based method for the detection of O-GlcNAc transferase activity in vitro.基于酶联免疫吸附测定(ELISA)的体外检测O-连接N-乙酰葡糖胺转移酶活性的新方法。
Prep Biochem Biotechnol. 2017 Aug 9;47(7):699-702. doi: 10.1080/10826068.2017.1303614. Epub 2017 Mar 15.

引用本文的文献

1
OSMI-4-based PROTACs do not influence -GlcNAc transferase and -GlcNAcylation levels in cells.基于OSMI-4的PROTACs不影响细胞中的N-乙酰葡糖胺转移酶和O-连接的N-乙酰葡糖胺化水平。
RSC Adv. 2025 Jul 18;15(31):25717-25723. doi: 10.1039/d5ra02801a. eCollection 2025 Jul 15.
2
O‑GlcNAcylation as an emerging molecular target for cholangiocarcinoma therapy (Review).O-连接的N-乙酰葡糖胺化作为胆管癌治疗的新兴分子靶点(综述)
Oncol Rep. 2025 Oct;54(4). doi: 10.3892/or.2025.8952. Epub 2025 Jul 19.
3
Dynamic regulation of Sec24C by phosphorylation and O-GlcNAcylation during cell cycle progression.
细胞周期进程中Sec24C通过磷酸化和O-连接N-乙酰葡糖胺化的动态调控
J Biol Chem. 2025 Jul 3;301(8):110456. doi: 10.1016/j.jbc.2025.110456.
4
Photoactivatable O-GlcNAc Transferase Library Enables Covalent Chemical Capture of Solvent-Exposed TPR Domain Interactions.光可激活的O-连接N-乙酰葡糖胺转移酶文库实现了对溶剂暴露的TPR结构域相互作用的共价化学捕获。
Chembiochem. 2025 Jan 2;26(1):e202400709. doi: 10.1002/cbic.202400709. Epub 2024 Nov 25.
5
O-GlcNAcylation: Crosstalk between Hemostasis, Inflammation, and Cancer.O-糖基化:止血、炎症和癌症之间的串扰。
Int J Mol Sci. 2024 Sep 13;25(18):9896. doi: 10.3390/ijms25189896.
6
O-GlcNAcylation: cellular physiology and therapeutic target for human diseases.O-连接的N-乙酰葡糖胺糖基化:细胞生理学与人类疾病的治疗靶点
MedComm (2020). 2023 Dec 19;4(6):e456. doi: 10.1002/mco2.456. eCollection 2023 Dec.
7
O-GlcNAcylation determines the translational regulation and phase separation of YTHDF proteins.O-GlcNAcylation 决定 YTHDF 蛋白的翻译调控和相分离。
Nat Cell Biol. 2023 Nov;25(11):1676-1690. doi: 10.1038/s41556-023-01258-x. Epub 2023 Nov 9.
8
Self-assembly of promoter DNA and RNA Pol II machinery into transcriptionally active biomolecular condensates.启动子 DNA 和 RNA 聚合酶 II 机器自我组装成转录活性的生物分子凝聚物。
Sci Adv. 2023 Oct 20;9(42):eadi4565. doi: 10.1126/sciadv.adi4565. Epub 2023 Oct 18.
9
Phage display uncovers a sequence motif that drives polypeptide binding to a conserved regulatory exosite of O-GlcNAc transferase.噬菌体展示技术揭示了一个序列基序,该基序驱动多肽结合到 O-糖基化转移酶保守的调节外位点。
Proc Natl Acad Sci U S A. 2023 Oct 17;120(42):e2303690120. doi: 10.1073/pnas.2303690120. Epub 2023 Oct 11.
10
O-GlcNAcylation: an important post-translational modification and a potential therapeutic target for cancer therapy.O-糖基化:一种重要的翻译后修饰,也是癌症治疗的潜在治疗靶点。
Mol Med. 2022 Sep 14;28(1):115. doi: 10.1186/s10020-022-00544-y.